Add to Favourites
To login click here
The global pharma 4.0 market is expected to see exponential growth in the next few years, reaching $38.44 billion in 2028 at a CAGR of 20.9%. This growth can be attributed to factors such as the shift towards value-based healthcare models, aging population, and increased demand for personalized medicine. Major trends in the market include personalized medicine, digital health technologies, and supply chain digitization. Top companies in the market include Alphabet Inc., Microsoft Corporation, Pfizer Inc., and Johnson & Johnson.